On Jun. 7, 2022, Veru announced that is had submitted an emergency use authorization (EUA) application to the…
On Jun. 7, 2022, Merck and Ridgeback Biotherapeutics announced the Annals of Internal Medicine had published additional data…
On Jun. 6, 2022, Pfizer further strengthened its commitment to United States manufacturing with a $120 million investment…
On Jun. 4, 2022, researchers reported that in areas with large cattle populations and a high prevalence of…
On Jun. 2, 2022, Novavax announced the submission of a request to the Medicines and Healthcare products Regulatory…
On Jun. 2, 2022, the U.S. National Institutes of Health announced that a large randomized, placebo-controlled clinical trial…
On Jun. 2, 2022, Moderna announced an agreement with the European Commission (EC) to amend their originally agreed…
On Jun. 1, 2022, the U.S. National Institutes of Health announced that an NIH funded study had found…
On May 31, 2022, Moderna and Takeda announced the transfer of the marketing authorization for Moderna’s COVID-19 vaccine…
On May 26, 2022, BD (Becton, Dickinson) announced a new high-throughput molecular diagnostic combination test for SARS-CoV-2 and…
On May 25, 2022, Pfizer and BioNTech announced topline safety, immunogenicity and vaccine efficacy data from a Phase…
On May 25, 2022, Novavax announced it was participating in a stage of the COVID-19 Vaccine Schedule Combinations…
On May 24, 2022, scientists at the Broad Institute of MIT and Harvard and the University of Massachusetts…
On May 20, 2022, Novavax announced the submission of a request to the European Medicines Agency (EMA) to…
On May 18, 2022, the U.S. National Institutes of Health announced it had awarded approximately $577 million to…
On May 19, 2022, the U.S. National Institutes of Health (NIH) announced that people who reported in a…
On May 19, 2022, WHO issued an emergency use listing (EUL) for CONVIDECIA, a vaccine manufactured by CanSino…
On May 18, 2022, LabCorp announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and…
On May 17, 2022, OraSure Technologies announced that its InteliSwabﾮ COVID-19 rapid tests detect the Omicron BA.2, BA.2.12.1,…
On May 17, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration expanded emergency use authorization…
On May 16, 2022, working with state and federal wildlife agencies and private and public zoos across Arizona,…
On May 13, 2022, Novavax announced the submission of a request for emergency use authorization to Taiwan’s Food…
On May 12, 2022, WHOﾒs COVID-19 Technology Access Pool and the Medicines Patent Pool finalized a licensing agreement…
On May 12, 2022, Cepheid announced it had received Emergency Use Authorization from the U.S. Food & Drug…
On May 12, 2022, the U.S. National Institutes of Health announced that it had licensed 11 COVID-19 research…
On May 11, 2022, Kaiser Permanente Washington Health Research Institute reported that new treatments for people at high…
On May 11, 2022, Lucira Health announced that it had submitted a request to the U.S. Food and…
On May 9, 2022, Lucira Health announced that both its COVID-19 & Flu and COVID-19 molecular tests have…
On May 6, 2022, Novavax announced that deliveries of it’s COVID-19 vaccine continued around the world and the…
On May 6, 2022, Novavax announced the submission of variations to the Australian Therapeutic Goods Agency (TGA) and…